Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:
Valeant Pharmaceuticals (VRX) : "No, I'm going to say don't buy. I think it's OK, but there are so many drug companies that are better."
Over on Real Money, Cramer says that when the stock of Facebook (FB) - Get Report gets crushed like it did today, he's more attracted to it than when it's soaring. Get his insights with a free trial subscription to Real Money.
Cramer and the AAP team say the decline in technology stocks is providing some buying opportunities. Find out what they're telling their investment club members about Facebook, Nvidia (NVDA) - Get Report and Activision Blizzard (ATVI) - Get Report and get in on the conversation with a free trial subscription to Action Alerts PLUS.
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To read a full recap of this episode of "Mad Money," click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
More of What's Trending on TheStreet:
- Trump's Latest Hotel Venture Focuses on Flea-Market Chic in Deep South
- Warren Buffett Has Lost More Than $1 Billion on Apple in Just the Past Week
- These Powerful Corporate Executives Could Make a Run at the Presidency in 2020
- The 10 Most Expensive Zip Codes to Live in the U.S.
At the time of publication, Cramer's Action Alerts PLUS had a position in FB, NVDA, ATVI.